Primary progressive multiple sclerosis
RecruitingOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
- Disease:Primary progressive multiple sclerosis
- Substances:–
Germany- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Germany127 clinical trials in Greifswald, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on hematologic malignancies and solid tumors, including innovative studies for acute myeloid leukemia and B-cell lymphoma. Novel therapeutic approaches combine targeted treatments with immunotherapy.
Research emphasizes personalized medicine approaches and combination therapies for improved patient outcomes.
Comprehensive studies addressing various types of migraine conditions, including breakthrough treatments for episodic and menstrual migraine. Advanced research in dementia diagnostics and management.
Focus on developing innovative therapeutic solutions for better patient care and quality of life.
Cutting-edge research in pulmonary arterial hypertension, exploring new treatment options and combination therapies. Studies evaluate both oral and inhaled medications for optimal disease management.
Emphasis on improving patient outcomes through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.